Skip to main content
. Author manuscript; available in PMC: 2020 Jan 2.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Apr 4;156(2):894–905.e3. doi: 10.1016/j.jtcvs.2018.03.112

FIGURE 2.

FIGURE 2.

Overall survival stratified by diagnosis groups, including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (IPF), and other (including pulmonary hypertension, α−1 anti-trypsin deficiency, and lymphangioleiomyomastosis). There is a statistically significant difference in survival among the groups (P<.007). Ninety-five percent confidence limits are represented by the thin lines. See Table E1 for survival and 95% confidence intervals separated by disease process.